share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director BLAYLOCK RONALD E

SEC announcement ·  Apr 27 01:24
Summary by Futu AI
Ronald E. Blaylock, a reporting person for Pfizer Inc. [PFE], has engaged in a transaction involving the company's stock on April 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for Mr. Blaylock is 66 Hudson Boulevard East, New York, NY, 10001-2192. The relationship of Mr. Blaylock to Pfizer Inc. was not specified in the provided information.
Ronald E. Blaylock, a reporting person for Pfizer Inc. [PFE], has engaged in a transaction involving the company's stock on April 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for Mr. Blaylock is 66 Hudson Boulevard East, New York, NY, 10001-2192. The relationship of Mr. Blaylock to Pfizer Inc. was not specified in the provided information.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.